FDA Approves Cuvposa (glycopyrrolate) for Chronic Drooling in Children

Aug 9th of 2010

Drugs Nervous System Musculoskeletal FEATURED

The U.S. Food and Drug Administration today approved Cuvposa (glycopyrrolate) Oral Solution to treat chronic severe drooling caused by neurologic disorders in children ages 3 years to 16 years. Drooling is normal in infants. But a significant proportion of the developmentally disabled population experiences drooling caused primarily by neuromuscular dysfunction that makes it hard to swallow. Cuvposa reduces drooling by lowering the volume of saliva produced.

FDA Approves New Injectable Osteoporosis Treatment for Postmenopausal Women

Jun 1st of 2010

Drugs Musculoskeletal Osteoporosis FEATURED

The U.S. Food and Drug Administration today approved Prolia, an injectable treatment for postmenopausal women with osteoporosis who are at high risk for fractures.

Hereditary Condition Causing Limb Weakness Traced to Gene for Menkes disease - a Rare Disorder

Mar 12th of 2010

Diseases Genetics Musculoskeletal FEATURED

A gene that causes a fatal childhood brain disorder can also cause adults to develop peripheral neuropathy, a condition resulting in weakness and decreased sensation in the hands and limbs, according to a study by researchers at the National Institutes of Health and other institutions. The study is the first to show that different mutations in the same gene cause the two seemingly unrelated disorders.

FDA Approves Xiaflex (collagenase clostridium histolyticum) for Debilitating Hand Condition

Feb 5th of 2010

Drugs Musculoskeletal

The U.S. Food and Drug Administration today approved Xiaflex (collagenase clostridium histolyticum) as the first drug to treat a progressive hand disease known as Dupuytren's contracture, which can affect a person's ability to straighten and properly use their fingers. Dupuytren's contracture affects the connective tissue found beneath the skin in the palm of the hand. Too much collagen can build up, forming thick, rope-like cords of tissue that can prevent the fingers from being able to rel...

Gene Duplication Identified in an Uncommon Form of Bone Cancer

Oct 8th of 2009

Diseases Cancer Musculoskeletal

Scientists have discovered that a familial form of a rare bone cancer called chordoma is explained not by typical types of changes or mutations in the sequence of DNA in a gene, but rather by the presence of a second copy of an entire gene. Inherited large structural changes, known as copy number variations (CNVs), have been implicated in some hereditary diseases but have seldom been reported as the underlying basis for a familial cancer. This finding appeared online Oct. 4, 2009, in Nature...

ADVERTISEMENT      |      ADVERTISE WITH US

FDA Approves New Total Ankle Replacement System

May 29th of 2009

Other News Musculoskeletal

The U.S. Food and Drug Administration today approved a total ankle replacement system for arthritic or deformed ankles that may preserve some range of motion in the joint.

Key Gaps Remain in Understanding Health Effects of Vitamin D

Aug 12th of 2008

Research Musculoskeletal Diet & Healthy Living

Despite considerable progress in research to understand the health effects of vitaminD, experts convened by the NIH to review the available data found major gaps in the evidence. The data are strongest in the area of bone health among elderly men and post-menopausal women, suggesting that increased vitamin D intake can improve bone health and prevent falls. For other age groups and health issues, though, it is too early to say conclusively whether more vitamin D might be beneficial.

FDA Investigation Leads to Prison Sentence for Woman Who Claimed to Cure Lou Gehrig's Disease

Dec 19th of 2007

Other News Musculoskeletal

The U.S. Food and Drug Administration's (FDA) Office of Criminal Investigations today announced that a New Jersey woman has been sentenced to 33 months in prison for falsely claiming that she could cure amyotrophic lateral sclerosis (ALS), commonly called Lou Gehrig's Disease.